Clinical Trial Update: Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back Pain [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/2 clinical trial evaluating intramuscular CELZ-201-DDT for chronic low back pain, currently recruiting to assess safety, tolerability, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Low Back Pain

Drugs mentioned

• CELZ-201-DDT

Snippet

Sponsor: Creative Medical Technology Holdings Inc | Conditions: Chronic Low-back Pain, Degenerative Disc Disease | Phase 1, Phase 2 | Status: RECRUITING